Latest Percodan Stories
In its latest blog post, A Forever Recovery, an open-ended drug and alcohol treatment program that gets clients off to a great start and gives them a solid foundation in recovery they can believe
TALLAHASSEE, Fla., March 5, 2011 /PRNewswire-USNewswire/ -- The Florida Society of Pain Management Providers (www.Flspmp.org) urges all to cease with the ridiculous comparisons of pain clinics to McDonald's(TM) and work to solve the issue of Rx diversion without resorting to such tactics.
CHADDS FORD, Pa., July 20 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals (Nasdaq: ENDP) will announce its second quarter 2010 financial results on July 30, 2010 and will host a conference call and webcast at 10:00 a.m. ET that day to discuss these results. David P.
CHADDS FORD, Pa., July 19 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals (Nasdaq: ENDP) CEO Dave Holveck, along with company executives, will mark Endo's 10th anniversary as a publicly traded company by ringing the opening bell at the NASDAQ Marketsite on Monday, July 19, in Times Square in New York. Endo and its employees will be recognizing this milestone at an important juncture in the company's history.
CHADDS FORD, Pa., July 15 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals (Nasdaq: ENDP) announced today the completion of its acquisition of HealthTronics, Inc. (Nasdaq: HTRN), a leading U.S. provider of urological products and services, located in Austin, Texas.
CHADDS FORD, Pa., July 12 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals (Nasdaq: ENDP) today announced the expiration of the subsequent offering period of the tender offer by its wholly owned subsidiary, HT Acquisition Corp., for all of the outstanding shares of common stock of HealthTronics, Inc.
- The parings of haberdine; also, any kind of fragments.